<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Fam Pract</journal-id><journal-title>BMC Family Practice</journal-title><issn pub-type="epub">1471-2296</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19166611</article-id><article-id pub-id-type="pmc">2642771</article-id><article-id pub-id-type="publisher-id">1471-2296-10-8</article-id><article-id pub-id-type="doi">10.1186/1471-2296-10-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Prevalence, evaluation and management of overactive bladder in primary care</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Cheung</surname><given-names>Wellman W</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>wellman.cheung@downstate.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Khan</surname><given-names>Nadia H</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>nadia.khan@downstate.edu</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Choi</surname><given-names>Karmina K</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>karmina.choi@downstate.edu</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Bluth</surname><given-names>Martin H</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>mbluth@med.wayne.edu</email></contrib><contrib id="A5" corresp="yes" contrib-type="author"><name><surname>Vincent</surname><given-names>Miriam T</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>miriam.vincent@downstate.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Urology, SUNY Downstate Medical Center, Brooklyn, New York, NY, USA</aff><aff id="I2"><label>2</label>Department of Pathology, Wayne State University/Detroit Medical Center, Detroit, MI, USA</aff><aff id="I3"><label>3</label>Department of Family Practice, SUNY Downstate Medical Center, Brooklyn, New York, NY, USA</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>23</day><month>1</month><year>2009</year></pub-date><volume>10</volume><fpage>8</fpage><lpage>8</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2296/10/8"/><history><date date-type="received"><day>22</day><month>5</month><year>2008</year></date><date date-type="accepted"><day>23</day><month>1</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Cheung et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Cheung et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>               Cheung               W               Wellman                              wellman.cheung@downstate.edu            </dc:author><dc:title>            Prevalence, evaluation and management of overactive bladder in primary care         </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>BMC Family Practice 10(1): 8-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2296(2009)10:1&#x0003c;8&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2296</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Patients with overactive bladder (OAB) are under-diagnosed in the primary care setting. Primary care physicians (PCP) approach to the patient and appropriate patient disclosure may contribute to under-diagnosis.</p></sec><sec sec-type="methods"><title>Methods</title><p>An outpatient primary care setting was used to determine the prevalence and characteristics of OAB. Patients who visited the family medicine outpatient clinic were invited to answer a self-administered questionnaire. It included questions on evidence of lower urinary tract symptoms (modified Overactive Bladder-Validated 8-question Screener [OAB-V8]), relevant medical and surgical history, and demographic data. Relationship between OAB and other independent variables were analyzed using chi-square and risk ratio (RR) analysis.</p></sec><sec><title>Results</title><p>Of 325 questionnaires distributed, 311 were returned completed. Patients ranged from 18 to 97 years, the majority women (74.0%) and African American (74.3%). OAB was present in 60.5% of men and 48.3% of women (<italic>p </italic>= 0.058). OAB was significantly associated with obesity (BMI &#x0003e; = 30) in women (<italic>p </italic>= 0.018, RR = 1.72), specifically obese premenopausal women (age &#x0003c; 55 years) (<italic>p </italic>= 0.011, RR = 1.98).</p></sec><sec><title>Conclusion</title><p>OAB prevalence is more than double and higher in men than previously reported. The relative risk for OAB is significantly greater in obese premenopausal women.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Overactive bladder (OAB) is a common disorder that negatively affects the quality of life [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>] of our patients and carries a large socioeconomic burden [<xref ref-type="bibr" rid="B3">3</xref>]. OAB is a condition caused by sudden involuntary contraction (over-activity) of the bladder detrusor muscles. According to the International Continence Society (ICS), it is characterized as urinary urgency, with or without urge incontinence, usually with frequency and nocturia, in the absence of causative infection or pathological conditions [<xref ref-type="bibr" rid="B4">4</xref>]. On the basis of a population-based survey of 16 776 men and women aged 40 years and older conducted by Milsom <italic>et al </italic>[<xref ref-type="bibr" rid="B5">5</xref>] in 6 countries, by telephone or direct interview, the prevalence of OAB in Europe has been estimated to be 15.6 and 17.4% for men and women respectively, with an overall prevalence of 16.6%. In the NOBLE survey in which 11740 Americans agreed to participate, overall prevalence of OAB was 16.9% in women and 16.0% in men [<xref ref-type="bibr" rid="B2">2</xref>].</p><p>It is expected that the primary care practitioner (PCP) will identify and initiate the management of patients with OAB [<xref ref-type="bibr" rid="B6">6</xref>]. Despite its high prevalence, many afflicted patients remain undiagnosed or untreated [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. The prevalence of OAB and its evaluation and management in primary care has never been studied in the US. Moreover, little epidemiologic data exists for OAB in ethnic/minority groups.</p></sec><sec sec-type="methods"><title>Methods</title><p>In a two week period, 325 patients aged 16 years and above who visited one of two family medicine outpatient centers, for non-urological issues, were invited to answer a self-administered questionnaire on urinary symptoms while waiting to be seen by their PCPs; physicians also completed a survey regarding their experience of patients with urinary symptoms in their practice (Additional files <xref ref-type="supplementary-material" rid="S1">1</xref> and <xref ref-type="supplementary-material" rid="S2">2</xref>). 311 patients agreed to fill the questionnaire. This study was approved by the Institutional Review Board, SUNY Downstate Medical Center, Brooklyn, NY.</p><p>The modified patient questionnaire included 8 questions on evidence of lower urinary tract symptoms (LUTS) (Overactive Bladder-Validated 8-question Screener [OAB-V8]) [<xref ref-type="bibr" rid="B8">8</xref>], 2 questions on stress urinary incontinence (SUI), and one question on incomplete emptying of the bladder during urination. Responses were answered on a 6-point Symptom Bother scale ranging from 0 (not at all) to 5 (a very great deal). An additional question asked about the effect of urinary symptoms on quality of life (QOL), with answers ranging from 0 (delighted) to 6 (terrible). The questionnaire also asked for data on demographic characteristics and relevant medical and surgical history. Patient weight and height were measured for calculating body mass index (BMI) (kg/m<sup>2</sup>).</p><p>Patients were considered to have OAB if their OAB-V8 score is &#x02265; 8 [<xref ref-type="bibr" rid="B8">8</xref>]. The presence of specific LUTS was then analyzed. Patients with OAB were categorized into subtypes based on their presence of particular symptoms. The categorization scheme and criteria for LUTS and OAB subtypes are shown in Table <xref ref-type="table" rid="T1">1</xref>. Patients who did not complete the OAB-V8 and SUI questions were excluded from the study. For the purpose of our analysis, patients were categorized into age groups of &#x0003c; 25, 25&#x02013;34, 35&#x02013;44, 45&#x02013;54, 55&#x02013;64, 65&#x02013;74, and &#x02265; 75. Women were considered to be pre-menopausal if age &#x0003c; 55 years, and postmenopausal if age &#x02265; 55.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Criteria for LUTS and OAB subtypes</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left"><italic>Idenitifcation criteria</italic></td></tr></thead><tbody><tr><td align="left"><italic>LUTS</italic></td><td></td></tr><tr><td align="left">&#x02003;Urgency</td><td align="left">Answer &#x02265;1 to any one of the three OAB-V8 questions on urge to urinate</td></tr><tr><td align="left">&#x02003;Frequency</td><td align="left">Answer &#x02265;1 to any one of the two OAB-V8 questions on frequent urination</td></tr><tr><td align="left">&#x02003;Nocturia</td><td align="left">Answer &#x02265;1 to the OAB-V8 question on nocturia</td></tr><tr><td align="left">&#x02003;Urge urinary incontinence (UUI)</td><td align="left">Answer &#x02265;1 to one of the two OAB-V8 questions on urine leakage associated with urge</td></tr><tr><td align="left">&#x02003;Stress urinary incontinence (SUI)</td><td align="left">Answer &#x02265;1 to one of the two questions on urine leakage associated with physical activities, sneezing, coughing, or laughing</td></tr><tr><td align="left">&#x02003;Mixed urinary incontinence (MUI)</td><td align="left">Meet the criteria for both UUI and SUI described above</td></tr><tr><td align="left">&#x02003;Incomplete emptying</td><td align="left">Answer &#x02265;1 to the question on incomplete emptying</td></tr><tr><td align="left"><italic>OAB subtypes (based on presence of above symptoms)</italic></td><td></td></tr><tr><td align="left">&#x02003;OAB with frequency alone (OAB-F)</td><td align="left">OAB-V8 score &#x02265;8 with symptoms of frequency and/or nocturia only</td></tr><tr><td align="left">&#x02003;OAB with urgency without incontinence (OAB-U)</td><td align="left">OAB-V8 score &#x02265;8 with symptoms of urgency without incontinence</td></tr><tr><td align="left">&#x02003;OAB with urge urinary incontinence (OAB-UUI)</td><td align="left">OAB-V8 score &#x02265;8 with symptoms of UUI and no SUI</td></tr><tr><td align="left">&#x02003;OAB with stress urinary incontinence (OAB-SUI)</td><td align="left">OAB-V8 score &#x02265;8 with symptoms of SUI and no UUI</td></tr><tr><td align="left">&#x02003;OAB with mixed urinary incontinence (OAB-MUI)</td><td align="left">OAB-V8 score &#x02265;8 with symptoms of MUI</td></tr></tbody></table><table-wrap-foot><p>LUTS = Lower urinary tract symptoms</p></table-wrap-foot></table-wrap><p>Unadjusted age- and sex-specific prevalence of OAB and sex-specific prevalence of LUTS and OAB subtypes were reported. The chi-square test was used to determine statistically significant differences between the two sexes. To determine the relationship between OAB prevalence and other factors (race, menopausal status, BMI, history of smoking and history of hysterectomy), covariates were first individually evaluated using the chi-square test. Statistically significant (<italic>p </italic>&#x0003c; .05) covariates were retained for risk ratio analysis. Patients were excluded from a specific analysis if they did not report on the variable to be analyzed. Results are presented as risk ratio and 95% confidence interval (RR, 95% CI).</p><p>All statistical analyses were performed using SPSS 15.0 for Windows.</p></sec><sec><title>Results</title><p>Table <xref ref-type="table" rid="T2">2</xref> reports the characteristics of patients studied including age, sex, ethnicity, education, BMI, smoking, prior surgical history and OAB status. Patients ranged from 18 to 97 years, the majority were women (74.0%) and Black (74.3%). Of the 219 women who reported their age, 49.3% were postmenopausal. OAB was present in 60.5% men and 48.3% women (<italic>p </italic>&#x0003e; .05). Prevalence of OAB increased with age in men but did not vary with age in women.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Characteristics of participants</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Characteristic, <italic>n </italic>(%)</td><td align="center" colspan="2">Male (<italic>n </italic>= 81)</td><td align="center" colspan="2">Female (<italic>n </italic>= 230)</td><td align="center" colspan="2">Total (<italic>N </italic>= 311)</td></tr></thead><tbody><tr><td align="left">Age, years</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x0003c; 25</td><td align="right">2</td><td align="left">(2.5)</td><td align="right">14</td><td align="left">(6.1)</td><td align="right">16</td><td align="left">(5.1)</td></tr><tr><td align="left">&#x02003;25&#x02013;34</td><td align="right">5</td><td align="left">(6.2)</td><td align="right">27</td><td align="left">(11.7)</td><td align="right">32</td><td align="left">(10.3)</td></tr><tr><td align="left">&#x02003;35&#x02013;44</td><td align="right">9</td><td align="left">(11.1)</td><td align="right">28</td><td align="left">(12.2)</td><td align="right">37</td><td align="left">(11.9)</td></tr><tr><td align="left">&#x02003;45&#x02013;54</td><td align="right">20</td><td align="left">(24.7)</td><td align="right">42</td><td align="left">(18.3)</td><td align="right">62</td><td align="left">(19.9)</td></tr><tr><td align="left">&#x02003;55&#x02013;64</td><td align="right">16</td><td align="left">(19.8)</td><td align="right">41</td><td align="left">(17.8)</td><td align="right">57</td><td align="left">(18.3)</td></tr><tr><td align="left">&#x02003;65&#x02013;74</td><td align="right">20</td><td align="left">(24.7)</td><td align="right">42</td><td align="left">(18.3)</td><td align="right">62</td><td align="left">(19.9)</td></tr><tr><td align="left">&#x02003;&#x02265;75</td><td align="right">8</td><td align="left">(9.9)</td><td align="right">25</td><td align="left">(10.9)</td><td align="right">33</td><td align="left">(10.6)</td></tr><tr><td align="left">&#x02003;Unknown</td><td align="right">1</td><td align="left">(1.2)</td><td align="right">11</td><td align="left">(4.8)</td><td align="right">12</td><td align="left">(3.9)</td></tr><tr><td align="left">Race</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Black</td><td align="right">57</td><td align="left">(70.4)</td><td align="right">174</td><td align="left">(75.7)</td><td align="right">231</td><td align="left">(74.3)</td></tr><tr><td align="left">&#x02003;Hispanic</td><td align="right">13</td><td align="left">(16.1)</td><td align="right">27</td><td align="left">(11.7)</td><td align="right">40</td><td align="left">(12.9)</td></tr><tr><td align="left">&#x02003;White</td><td align="right">0</td><td align="left">(0.0)</td><td align="right">3</td><td align="left">(1.3)</td><td align="right">3</td><td align="left">(0.01)</td></tr><tr><td align="left">&#x02003;Other/Not stated</td><td align="right">11</td><td align="left">(13.6)</td><td align="right">26</td><td align="left">(11.3)</td><td align="right">37</td><td align="left">(11.9)</td></tr><tr><td align="left">Education</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Less than high school</td><td align="right">8</td><td align="left">(9.9)</td><td align="right">13</td><td align="left">(5.7)</td><td align="right">21</td><td align="left">(6.8)</td></tr><tr><td align="left">&#x02003;High school graduate</td><td align="right">24</td><td align="left">(29.6)</td><td align="right">72</td><td align="left">(31.3)</td><td align="right">96</td><td align="left">(30.9)</td></tr><tr><td align="left">&#x02003;Some college/college graduate</td><td align="right">19</td><td align="left">(23.5)</td><td align="right">47</td><td align="left">(20.4)</td><td align="right">66</td><td align="left">(21.2)</td></tr><tr><td align="left">&#x02003;Graduate school</td><td align="right">4</td><td align="left">(4.9)</td><td align="right">13</td><td align="left">(5.7)</td><td align="right">17</td><td align="left">(5.5)</td></tr><tr><td align="left">&#x02003;Not stated</td><td align="right">26</td><td align="left">(32.1)</td><td align="right">85</td><td align="left">(37.0)</td><td align="right">111</td><td align="left">(35.7)</td></tr><tr><td align="left">Body mass index (BMI), kg/m<sup>2</sup></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;&#x0003c; 25.0</td><td align="right">12</td><td align="left">(14.8)</td><td align="right">38</td><td align="left">(16.5)</td><td align="right">50</td><td align="left">(16.1)</td></tr><tr><td align="left">&#x02003;25.0&#x02013;29.9</td><td align="right">27</td><td align="left">(33.3)</td><td align="right">79</td><td align="left">(34.3)</td><td align="right">106</td><td align="left">(34.1)</td></tr><tr><td align="left">&#x02003;&#x02265;30</td><td align="right">31</td><td align="left">(38.3)</td><td align="right">96</td><td align="left">(41.7)</td><td align="right">127</td><td align="left">(40.8)</td></tr><tr><td align="left">&#x02003;Not stated</td><td align="right">11</td><td align="left">(13.6)</td><td align="right">17</td><td align="left">(7.4)</td><td align="right">28</td><td align="left">(9.0)</td></tr><tr><td align="left">History of smoking*</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Yes</td><td align="right">36</td><td align="left">(44.4)</td><td align="right">59</td><td align="left">(25.7)</td><td align="right">95</td><td align="left">(30.5)</td></tr><tr><td align="left">&#x02003;No</td><td align="right">45</td><td align="left">(55.6)</td><td align="right">171</td><td align="left">(74.3)</td><td align="right">216</td><td align="left">(69.5)</td></tr><tr><td align="left">Previous surgical history</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Bladder surgery**</td><td align="right">0</td><td align="left">(0.0)</td><td align="right">8</td><td align="left">(3.5)</td><td align="right">8</td><td align="left">(2.6)</td></tr><tr><td align="left">&#x02003;Urinary leakage surgery**</td><td align="right">0</td><td align="left">(0.0)</td><td align="right">1</td><td align="left">(0.4)</td><td align="right">1</td><td align="left">(0.3)</td></tr><tr><td align="left">&#x02003;Hysterectomy***</td><td align="right">--</td><td align="left">--</td><td align="right">49</td><td align="left">(21.3)</td><td align="right">--</td><td align="left">--</td></tr><tr><td align="left">&#x02003;Prostate surgery</td><td align="right">5</td><td align="left">(6.2)</td><td align="right">--</td><td align="left">--</td><td align="right">--</td><td align="left">--</td></tr><tr><td align="left">OAB status</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Normal</td><td align="right">32</td><td align="left">(39.5)</td><td align="right">119</td><td align="left">(51.7)</td><td align="right">151</td><td align="left">(48.5)</td></tr><tr><td align="left">&#x02003;OAB with UI</td><td align="right">37</td><td align="left">(45.7)</td><td align="right">92</td><td align="left">(40.0)</td><td align="right">129</td><td align="left">(41.5)</td></tr><tr><td align="left">&#x02003;OAB without UI</td><td align="right">12</td><td align="left">(14.8)</td><td align="right">19</td><td align="left">(8.3)</td><td align="right">31</td><td align="left">(10.0)</td></tr></tbody></table></table-wrap><p>Analysis of the 151 patients without OAB (119 women, 32 men) shows that women reported 53.8% frequency and 44.5% nocturia. Urgency was present in 25.2% of the 119 women, with UUI in 23.3% of these women. SUI was present in 25.2% of the 119 women. Among the men without OAB there were less reported lower urinary tract symptoms (31.3% frequency, 46.9% nocturia and 12.5% urgency).</p><p>Table <xref ref-type="table" rid="T3">3</xref> identifies the prevalence of LUTS and OAB subtypes in men and women with OAB. Each of the three OAB-defining symptoms, urgency, frequency, and nocturia, were present in almost 90% of OAB patients. UUI was highly prevalent in both genders, however more so in women (79.3% vs 75.5%, <italic>p </italic>&#x0003e; .05). SUI was significantly more prevalent in women (60.4% vs 36.7%, <italic>p </italic>= .006). Incomplete emptying, a symptom often accompanying OAB, was present in about half OAB patients and was similar in both men and women (53.1% vs 47.7%).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Prevalence of LUTS and OAB subtypes by gender</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><italic>n </italic>(%)</td><td align="center">Male (<italic>n </italic>= 49)</td><td align="center">Female (<italic>n </italic>= 111)</td><td align="center"><italic>p </italic>value</td></tr></thead><tbody><tr><td align="left">Symptoms</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Urgency</td><td align="center">44 (89.8)</td><td align="center">100 (90.1)</td><td align="center">.954</td></tr><tr><td align="left">&#x02003;Frequency</td><td align="center">48 (98.0)</td><td align="center">110 (99.1)</td><td align="center">.550</td></tr><tr><td align="left">&#x02003;Nocturia</td><td align="center">41 (83.7)</td><td align="center">101 (91.0)</td><td align="center">.177</td></tr><tr><td align="left">&#x02003;UUI</td><td align="center">37 (75.5)</td><td align="center">88 (79.3)</td><td align="center">.595</td></tr><tr><td align="left">&#x02003;SUI</td><td align="center">18 (36.7)</td><td align="center">67 (60.4)</td><td align="center">.006</td></tr><tr><td align="left">&#x02003;Incomplete emptying</td><td align="center">26 (53.1)</td><td align="center">53 (47.7)</td><td align="center">.535</td></tr><tr><td align="left">OAB subtypes</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;OAB-F</td><td align="center">1 (2.0)</td><td align="center">4 (3.6)</td><td align="center">.600</td></tr><tr><td align="left">&#x02003;OAB-U</td><td align="center">11 (22.4)</td><td align="center">15 (13.5)</td><td align="center">.158</td></tr><tr><td align="left">&#x02003;OAB-UUI</td><td align="center">20 (40.8)</td><td align="center">25 (22.5)</td><td align="center">.018</td></tr><tr><td align="left">&#x02003;OAB-SUI</td><td align="center">0 (0.0)</td><td align="center">4 (3.6)</td><td align="center">.178</td></tr><tr><td align="left">&#x02003;OAB-MUI</td><td align="center">17 (34.7)</td><td align="center">63 (56.8)</td><td align="center">.010</td></tr><tr><td align="left">OAB with incontinence</td><td align="center">37 (75.5)</td><td align="center">92 (82.9)</td><td align="center">.277</td></tr></tbody></table><table-wrap-foot><p>UUI = urge urinary incontinence, SUI = stress urinary incontinence, OAB-F = OAB with frequency alone,</p><p>OAB-U = OAB with urgency without incontinence, OAB-UUI = OAB with urge urinary incontinence,</p><p>OAB-SUI = OAB with stress urinary incontinence, OAB-MUI = OAB with mixed urinary incontinence</p></table-wrap-foot></table-wrap><p>The sex-specific differences in OAB subtypes found in this study reveal that the OAB-MUI subtype was significantly more common in women (56.8% women vs 34.7% men, <italic>p </italic>= .010) and OAB-UUI was significantly more common in men (40.8% vs 22.5%, <italic>p </italic>= .018). OAB-U was also more prevalent in men, and men were less likely to have OAB with incontinence than women (<italic>p </italic>&#x0003e; .05).</p><p>Age- and sex-specific prevalence of OAB and OAB subtypes are shown in Figure <xref ref-type="fig" rid="F1">1</xref>. Prevalence of OAB increased with age in men but not in women (Figure <xref ref-type="fig" rid="F1">1A</xref>). Prevalence of OAB-U increases steadily after age 30 in both genders and peaks at age 60 for women and at age 70 for men (Figure <xref ref-type="fig" rid="F1">1B</xref>). For OAB-UUI, the prevalence in men increases from 0% at age 20 to a peak of 16.3% by age 50 (Figure <xref ref-type="fig" rid="F1">1C</xref>). OAB-UUI prevalence in women is lower than men in all age groups except those women younger than 40. For OAB-MUI, the prevalence is higher in women at most ages (Figure <xref ref-type="fig" rid="F1">1D</xref>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Prevalence of OAB subtypes by age and sex</bold>. Data represent percent (%) prevalence of male and female patients by age for (A) all subtypes, (B) OAB-U, (C) OAB-UUI, (D) OAB &#x02013; MUI. OAB-U = OAB with urgency without incontinence, OAB-UUI = OAB with urge urinary incontinence, OAB-MUI = OAB with mixed urinary incontinence.</p></caption><graphic xlink:href="1471-2296-10-8-1"/></fig><p>Unexpectedly, OAB was present in 53.2% pre-menopausal women and 44.4% postmenopausal women (Table <xref ref-type="table" rid="T4">4</xref>). Premenopausal women have a higher prevalence of OAB-MUI (64.4% vs 52.1%, <italic>p </italic>&#x0003e; .05) than post-menopausal women with OAB. Postmenopausal women have a higher prevalence of OAB-U (18.8% vs 10.2%, <italic>p </italic>&#x0003e; .05) and OAB-UUI (25.0% vs 15.3%, <italic>p </italic>&#x0003e; .05).</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Prevalence of LUTS and OAB subtypes by menopausal status</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><italic>n </italic>(%)</td><td align="center">Premenopause (<italic>n </italic>= 111)</td><td align="center">Postmenopause (<italic>n </italic>= 108)</td><td align="center"><italic>p </italic>value</td></tr></thead><tbody><tr><td align="left">OAB positive</td><td align="center">59 (53.2)</td><td align="center">48 (44.4)</td><td align="center">.197</td></tr><tr><td align="left">OAB subtypes</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;OAB-F</td><td align="center">2 (3.4)</td><td align="center">2 (4.2)</td><td align="center">.833</td></tr><tr><td align="left">&#x02003;OAB-U</td><td align="center">6 (10.2)</td><td align="center">9 (18.8)</td><td align="center">.204</td></tr><tr><td align="left">&#x02003;OAB-UUI</td><td align="center">9 (15.3)</td><td align="center">12 (25.0)</td><td align="center">.207</td></tr><tr><td align="left">&#x02003;OAB-SUI</td><td align="center">4 (6.8)</td><td align="center">0 (0)</td><td align="center">.066</td></tr><tr><td align="left">&#x02003;OAB-MUI</td><td align="center">38 (64.4)</td><td align="center">25 (52.1)</td><td align="center">.198</td></tr><tr><td align="left">OAB with incontinence</td><td align="center">51 (86.4)</td><td align="center">37 (77.1)</td><td align="center">.208</td></tr></tbody></table><table-wrap-foot><p>OAB-F = OAB with frequency alone, OAB-U = OAB with urgency without incontinence,</p><p>OAB-UUI = OAB with urge urinary incontinence, OAB-SUI = OAB with stress urinary incontinence,</p><p>OAB-MUI = OAB with mixed urinary incontinence</p></table-wrap-foot></table-wrap><p>OAB was significantly associated with obesity (BMI &#x02265; 30) in women (<italic>p </italic>= .018) (Table <xref ref-type="table" rid="T5">5</xref>). However when menopause status was controlled, such association was only found in obesity pre-menopausal women (<italic>p </italic>= .013), who had a 2-fold increased risk for OAB (RR = 1.98, 1.05&#x02013;3.74). Overall, the risk for obese women to have OAB is 1.72 times (95% CI 1.04&#x02013;2.84) that of women with normal weight. OAB is significantly associated with incomplete bladder emptying (<italic>p </italic>&#x0003c; .001) and with SUI (<italic>p </italic>&#x0003c; .001) in both men and women. OAB was not shown to vary with race, cigarette use, history of hysterectomy, menopause status in women or BMI in men (<italic>p </italic>&#x0003e; .05).</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Relative risk for OAB by BMI category</p></caption><table frame="hsides" rules="groups"><tbody><tr><td></td><td align="center" colspan="3">Risk Ratio (RR)**</td></tr><tr><td align="left">Comparison group*</td><td align="center">RR</td><td align="center">95% CI</td><td align="center"><italic>p</italic></td></tr><tr><td colspan="1"><hr></hr></td><td colspan="3"><hr></hr></td></tr><tr><td align="left">All women</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;BMI 25.0&#x02013;29.9</td><td align="center">---</td><td align="center">---</td><td align="center">.091</td></tr><tr><td align="left">&#x02003;BMI &#x02265;30.0</td><td align="center">1.72</td><td align="center">1.04 &#x02013; 2.84</td><td align="center">.018</td></tr><tr><td align="left">Premenopausal women</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;BMI 25.0&#x02013;29.9</td><td align="center">---</td><td align="center">---</td><td align="center">.394</td></tr><tr><td align="left">&#x02003;BMI &#x02265;30.0</td><td align="center">1.98</td><td align="center">1.05 &#x02013; 3.74</td><td align="center">.011</td></tr><tr><td align="left">Postmenopausal women</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;BMI 25.0&#x02013;29.9</td><td align="center">---</td><td align="center">---</td><td align="center">.072</td></tr><tr><td align="left">&#x02003;BMI &#x02265;30.0</td><td align="center">---</td><td align="center">---</td><td align="center">.188</td></tr></tbody></table><table-wrap-foot><p>*Women in the corresponding age group with BMI &#x0003c; 25 served as the reference group</p><p>** Risk ratio was calculated only when <italic>p </italic>&#x0003c; .05;</p><p>Risk ratio = prevalence of OAB in women with comparison BMI/prevalence of OAB in women with reference BMI of &#x0003c; 25</p></table-wrap-foot></table-wrap></sec><sec><title>Discussion</title><p>In this study we investigated the prevalence of OAB, its evaluation in primary care using a patient questionnaire. We found an OAB prevalence that is more than double that reported in a recent US population-based study [<xref ref-type="bibr" rid="B2">2</xref>], a finding not previously reported [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. Variations from earlier studies may be attributed to the methodology of data collection and our non-traditional minority, predominantly female target population. This study used a clinically validated questionnaire [<xref ref-type="bibr" rid="B8">8</xref>] with added questions focusing on stress urinary incontinence to identify OAB patients in primary care. Unlike two population-based studies [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B7">7</xref>] in which responses regarding LUTS were elicited from non-institutionalized individuals through telephone interviews, our questionnaire relies on self-report by primary care physicians and outpatients. In this sense, our data collection method resembles one office-based PCP study [<xref ref-type="bibr" rid="B7">7</xref>], which had an OAB prevalence estimate that was high (26.5%) and most nearly resembles our results. In all three previous studies cited above, OAB was defined based on the presence and/or frequency of specific LUTS, and the study populations were predominately white. Our study differs in that the OAB criteria are based on scoring on a symptom bother scale and the patient population is predominately black. These differences may explain in part the discrepancy in OAB prevalence observed in the current study compared to those previously reported in the literature.</p><p>Significantly more men compared to women with OAB have OAB-UUI in this study. In addition, OAB with incontinence is more common than OAB without incontinence in our study in both men and women. These results are in sharp contrast to data reported previously [<xref ref-type="bibr" rid="B2">2</xref>], which showed women to be more likely to have OAB-UUI, and men to be more likely to have OAB without incontinence. However, when UUI is taken as a symptom, the higher prevalence we found of UUI and SUI in women than in men are consistent with other studies [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. Most studies on female UI have reported SUI as more common than UUI,[<xref ref-type="bibr" rid="B7">7</xref>] especially in younger women,[<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>] while MUI was the major presentation overall [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. We find that most women who have OAB have OAB-MUI. However, UUI and OAB-UUI are more prevalent than SUI and OAB-SUI in women with OAB in our study. This finding is supported by others [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>] who reported black women to have lower rates of SUI but higher rates of UUI than white women. The significant association between OAB and SUI we found is also supported [<xref ref-type="bibr" rid="B10">10</xref>]. While most studies have reported white women to have higher risk for UI in general [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>], how this would affect the characterization of OAB prevalence in such population could be the focus of future investigation.</p><p>As in earlier reports [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>], we find OAB prevalence to increase with advancing age, however this relationship is observed only in men and we do not understand why this association is not found in women. We also find a significant association between OAB and incomplete emptying of the bladder in both men and women. Bladder outlet obstruction leading to incomplete emptying is commonly seen in benign prostate hyperplasia (BPH) in older men. Studies have reported that OAB often coexists with BPH [<xref ref-type="bibr" rid="B15">15</xref>], and the associated incomplete emptying of the bladder as a cause of OAB has been discussed in the clinical scenario of BPH [<xref ref-type="bibr" rid="B16">16</xref>]. However, the relation between OAB and incomplete emptying in women may involve mechanisms other than obstruction [<xref ref-type="bibr" rid="B16">16</xref>].</p><p>Obesity as a risk factor for OAB [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B10">10</xref>] and UI [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B17">17</xref>] has been previously reported. The risk for OAB we found for premenopausal obese women (1.98) is similar to that reported by Stewart et al [<xref ref-type="bibr" rid="B2">2</xref>] (2.2) in obese women with OAB-UUI. In concordance with results reported by Stewart et al, we do not find an association between OAB and obesity in men or in the general population studied. There has been no report of the relationship between smoking and OAB, and smoking is shown as a risk factor for UI in some studies [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B17">17</xref>] but not others [<xref ref-type="bibr" rid="B9">9</xref>]. We do not find any significant association for OAB and smoking in men or women.</p><p>Previous studies have demonstrated that hysterectomy increased the risk for UUI [<xref ref-type="bibr" rid="B18">18</xref>] but not SUI [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. Hysterectomy is thought to contribute to UI through pelvic nerves or pelvic floor damage. Its relationship and contribution to OAB has not been studied, and we do not find any significant association between OAB and hysterectomy in pre- or postmenopausal women.</p><p>A number of limitations should be considered when interpreting the results of this study. Language barriers and cultural differences in how comfortable patients would voluntarily answer particular questions are challenges in implementing a questionnaire-based study. Measures have been taken to ensure that questionnaires were distributed to all qualified patients who visited the clinic, with the intention to minimize overestimation of prevalence. In our present study the response rate was 95%. The majority of our OAB patients have all 3 cardinal symptoms (frequency, nocturia, and urgency/UUI), suggesting that they have OAB and should be evaluated and managed as such.</p></sec><sec><title>Conclusion</title><p>The high prevalence of OAB found in this study suggests that the needs of many of our patients with OAB may not be met by their primary care providers. Increasing the awareness and knowledge of OAB among PCPs and adopting effective clinical approaches such as a reliable, valid and "user-friendly" screening questionnaire may serve to both allow patients with urinary symptoms to comfortably report their bladder related complaints and increase the ability of PCP's to recognize, evaluate and treat OAB. Future studies should focus on differentiating OAB patients across various ethnic groups and in diverse clinic settings. Identifying culturally sensitive strategies for evaluating and managing primary care patients with OAB may help to decrease the burden of OAB and better serve our patients.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>Patient and data recruitment (WC, NK, KC, MV). Manuscript preparation (WC, NK, KC, MB, MV). Data and statistical analysis (WC, NK, KC, MB, MV). All authors read and approved the final manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2296/10/8/prepub"/></p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p><bold>Physician Survey.</bold></p></caption><media xlink:href="1471-2296-10-8-S1.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p><bold>Urinary Symptom Questionnaire.</bold></p></caption><media xlink:href="1471-2296-10-8-S2.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abrams</surname><given-names>P</given-names></name><name><surname>Kelleher</surname><given-names>CJ</given-names></name><name><surname>Kerr</surname><given-names>LA</given-names></name><name><surname>Rogers</surname><given-names>RG</given-names></name></person-group><article-title>Overactive bladder significantly affects quality of life</article-title><source>Am J Manag Care</source><year>2000</year><volume>6</volume><fpage>S580</fpage><lpage>S590</lpage><pub-id pub-id-type="pmid">11183901</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>WF</given-names></name><name><surname>Van Rooyen</surname><given-names>JB</given-names></name><name><surname>Cundiff</surname><given-names>GW</given-names></name><name><surname>Abrams</surname><given-names>P</given-names></name><name><surname>Herzog</surname><given-names>AR</given-names></name><name><surname>Corey</surname><given-names>R</given-names></name><name><surname>Hunt</surname><given-names>T</given-names></name><name><surname>Wein</surname><given-names/></name></person-group><article-title>Prevalence and burden of overactive bladder in the United States</article-title><source>World J Urol</source><year>2003</year><volume>20</volume><fpage>327</fpage><pub-id pub-id-type="pmid">12811491</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>TW</given-names></name><name><surname>Wagner</surname><given-names>TH</given-names></name><name><surname>Bentkover</surname><given-names>JD</given-names></name><name><surname>LeBlanc</surname><given-names>K</given-names></name><name><surname>Piancentini</surname><given-names>A</given-names></name><name><surname>Stewart</surname><given-names>WF</given-names></name><name><surname>Corey</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>SZ</given-names></name><name><surname>Hunt</surname><given-names>TL</given-names></name></person-group><article-title>Estimated economic costs of overactive bladder in the United States</article-title><source>Urology</source><year>2003</year><volume>61</volume><fpage>1123</fpage><pub-id pub-id-type="pmid">12809878</pub-id><pub-id pub-id-type="doi">10.1016/S0090-4295(03)00009-8</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abrams</surname><given-names>P</given-names></name><name><surname>Cardozo</surname><given-names>L</given-names></name><name><surname>Fall</surname><given-names>M</given-names></name><name><surname>Griffiths</surname><given-names>D</given-names></name><name><surname>Rosier</surname><given-names>P</given-names></name><name><surname>Ulmsten</surname><given-names>U</given-names></name><name><surname>van Kerrebroeck</surname><given-names>P</given-names></name><name><surname>Victor</surname><given-names>A</given-names></name><name><surname>Wein</surname><given-names>A</given-names></name></person-group><article-title>The standardization of terminology of lower urinary tract function: Report from the standardization sub-committee of the International Continence Society</article-title><source>Neurourol Urodyn</source><year>2002</year><volume>21</volume><fpage>167</fpage><pub-id pub-id-type="pmid">11857671</pub-id><pub-id pub-id-type="doi">10.1002/nau.10052</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Milsom</surname><given-names>I</given-names></name><name><surname>Abrams</surname><given-names>P</given-names></name><name><surname>Cardozo</surname><given-names>L</given-names></name><name><surname>Roberts</surname><given-names>RG</given-names></name><name><surname>Th&#x000fb;roff</surname><given-names>JW</given-names></name><name><surname>Wein</surname><given-names>AJ</given-names></name></person-group><article-title>How wide-spread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study</article-title><source>BJU Int</source><year>2001</year><volume>87</volume><fpage>760</fpage><pub-id pub-id-type="pmid">11412210</pub-id><pub-id pub-id-type="doi">10.1046/j.1464-410x.2001.02228.x</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>MT</given-names></name><name><surname>Dmochowski</surname><given-names>RR</given-names></name></person-group><article-title>Overactive bladder: Evaluation and management in primary care</article-title><source>Cleve Clin J Med</source><year>2005</year><volume>72</volume><fpage>149</fpage><pub-id pub-id-type="pmid">15757170</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goepel</surname><given-names>M</given-names></name><name><surname>Hoffmann</surname><given-names>JA</given-names></name><name><surname>Piro</surname><given-names>M</given-names></name><name><surname>Rubben</surname><given-names>H</given-names></name><name><surname>Michel</surname><given-names>MC</given-names></name></person-group><article-title>Prevalence and Physician Awareness of Symptoms of Urinary Bladder Dysfunction</article-title><source>Eur Urol</source><year>2002</year><volume>41</volume><fpage>234</fpage><pub-id pub-id-type="pmid">12180221</pub-id><pub-id pub-id-type="doi">10.1016/S0302-2838(02)00014-3</pub-id></citation></ref><ref id="B8"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Coyne</surname><given-names>K</given-names></name><name><surname>Margolis</surname><given-names>M</given-names></name><name><surname>Zyczynski</surname><given-names>T</given-names></name><name><surname>Elinoff</surname><given-names>V</given-names></name><name><surname>Roberts</surname><given-names>RG</given-names></name></person-group><article-title>Validation of an OAB Screener in a primary care patient population in the US</article-title><source>Presented at the ICS and IUCA 2004 Scientific Programme, August 25&#x02013;27, Paris, France</source><year>2004</year></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Melville</surname><given-names>JL</given-names></name><name><surname>Katon</surname><given-names>W</given-names></name><name><surname>Delaney</surname><given-names>K</given-names></name><name><surname>Newton</surname><given-names>K</given-names></name></person-group><article-title>Urinary incontinence in US women: A population-based study</article-title><source>Arch Intern Med</source><year>2005</year><volume>165</volume><fpage>537</fpage><pub-id pub-id-type="pmid">15767530</pub-id><pub-id pub-id-type="doi">10.1001/archinte.165.5.537</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teleman</surname><given-names>PM</given-names></name><name><surname>Lidfeldt</surname><given-names>J</given-names></name><name><surname>Nerbrand</surname><given-names>C</given-names></name><name><surname>Samsioe</surname><given-names>G</given-names></name><name><surname>Mattiasson</surname><given-names>A</given-names></name></person-group><article-title>Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women</article-title><source>BJOG</source><year>2004</year><volume>111</volume><fpage>600</fpage><pub-id pub-id-type="pmid">15198789</pub-id><pub-id pub-id-type="doi">10.1111/j.1471-0528.2004.00137.x</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thom</surname><given-names>DH</given-names></name><name><surname>Eeden</surname><given-names>SK Van den</given-names></name><name><surname>Ragins</surname><given-names>AI</given-names></name><name><surname>Wassel-Fyr</surname><given-names>C</given-names></name><name><surname>Vittinghof</surname><given-names>E</given-names></name><name><surname>Subak</surname><given-names>LL</given-names></name><etal></etal></person-group><article-title>Differences in prevalence of urinary incontinence by race/ethnicity</article-title><source>J Urol</source><year>2006</year><volume>175</volume><fpage>259</fpage><pub-id pub-id-type="pmid">16406923</pub-id><pub-id pub-id-type="doi">10.1016/S0022-5347(05)00039-X</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JS</given-names></name><name><surname>Grady</surname><given-names>D</given-names></name><name><surname>Ouslander</surname><given-names>JG</given-names></name><name><surname>Herzog</surname><given-names>AR</given-names></name><name><surname>Varner</surname><given-names>RE</given-names></name><name><surname>Posner</surname><given-names>SF</given-names></name></person-group><article-title>Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart &#x00026; Estrogen/Progestin Replacement Study (HERS) Research Group</article-title><source>Obstet Gynecol</source><year>1999</year><volume>94</volume><fpage>66</fpage><pub-id pub-id-type="pmid">10389720</pub-id><pub-id pub-id-type="doi">10.1016/S0029-7844(99)00263-X</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grodstein</surname><given-names>F</given-names></name><name><surname>Fretts</surname><given-names>R</given-names></name><name><surname>Lifford</surname><given-names>K</given-names></name><name><surname>Resnick</surname><given-names>N</given-names></name><name><surname>Curhan</surname><given-names>G</given-names></name></person-group><article-title>Association of age, race, and obstetric history with urinary symptoms among women in the Nurses' Health Study</article-title><source>Am J Obstet Gynecol</source><year>2003</year><volume>189</volume><fpage>428</fpage><pub-id pub-id-type="pmid">14520212</pub-id><pub-id pub-id-type="doi">10.1067/S0002-9378(03)00361-2</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sampselle</surname><given-names>CM</given-names></name><name><surname>Harlow</surname><given-names>SD</given-names></name><name><surname>Skurnick</surname><given-names>J</given-names></name><name><surname>Brubaker</surname><given-names>L</given-names></name><name><surname>Bondarenko</surname><given-names>I</given-names></name></person-group><article-title>Urinary incontinence predictors and life impact in ethnically diverse perimenopausal women</article-title><source>Obstet Gynecol</source><year>2002</year><volume>100</volume><fpage>1230</fpage><pub-id pub-id-type="pmid">12468167</pub-id><pub-id pub-id-type="doi">10.1016/S0029-7844(02)02241-X</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knutson</surname><given-names>T</given-names></name><name><surname>Edlund</surname><given-names>C</given-names></name><name><surname>Fall</surname><given-names>M</given-names></name><name><surname>Dahlstrand</surname><given-names>C</given-names></name></person-group><article-title>BPH with coexisiting overactive bladder dysfunction &#x02013; an everyday urological dilemma</article-title><source>Neurourol Urodynam</source><year>2001</year><volume>20</volume><fpage>237</fpage><pub-id pub-id-type="doi">10.1002/nau.1001</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mostwin</surname><given-names>JL</given-names></name></person-group><article-title>Pathophysiology: The varieties of bladder overactivity</article-title><source>Urology</source><year>2002</year><volume>60</volume><fpage>22</fpage><pub-id pub-id-type="pmid">12493346</pub-id><pub-id pub-id-type="doi">10.1016/S0090-4295(02)01788-0</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hannestad</surname><given-names>YS</given-names></name><name><surname>Rortveit</surname><given-names>G</given-names></name><name><surname>Daltveit</surname><given-names>AK</given-names></name><name><surname>Hunskaar</surname><given-names>S</given-names></name></person-group><article-title>Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT study</article-title><source>BJOG</source><year>2003</year><volume>110</volume><fpage>247</fpage><pub-id pub-id-type="pmid">12628262</pub-id><pub-id pub-id-type="doi">10.1046/j.1471-0528.2003.02327.x</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaart</surname><given-names>CH van der</given-names></name><name><surname>Bom</surname><given-names>JG van der</given-names></name><name><surname>de Leeuw</surname><given-names>JR</given-names></name><name><surname>Roovers</surname><given-names>JP</given-names></name><name><surname>Heintz</surname><given-names>AP</given-names></name></person-group><article-title>The contribution of hysterectomy to the occurrence of urge and stress urinary incontinence symptoms</article-title><source>BJOG</source><year>2002</year><volume>109</volume><fpage>149</fpage><pub-id pub-id-type="pmid">11911100</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Tayrac</surname><given-names>R</given-names></name><name><surname>Chevalier</surname><given-names>N</given-names></name><name><surname>Chauveaud-Lambling</surname><given-names>A</given-names></name><name><surname>Gervaise</surname><given-names>A</given-names></name><name><surname>Fernandez</surname><given-names>H</given-names></name></person-group><article-title>Risk of urge and stress urinary incontinence at long-term follow-up after vaginal hysterectomy</article-title><source>Am J Obstet Gynecol</source><year>2004</year><volume>191</volume><fpage>90</fpage><pub-id pub-id-type="pmid">15295347</pub-id><pub-id pub-id-type="doi">10.1016/j.ajog.2004.01.031</pub-id></citation></ref></ref-list></back></article>